Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with high grade glioma. Armodafinil may help relieve fatigue in patients with high grade glioma.

Research Base: Alliance for Clinical Trials in Oncology
NCT ID: NCT01781468
NCI Protocol Number: A221101
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Armodafinil 150 mg; Placebo; Armodafinil 250 mg

Condition

Fatigue

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP